American College of Rheumatology Statement on CMS Medicare Advantage Final Rule

In August 2018, the CMS announced that Medicare Advantage (MA) plans would be allowed to utilize step therapy for Part B drugs. The American College of Rheumatology (ACR) expressed strong concerns about this proposal. The rheumatology community...
17-May-2019 4:50 PM EDT Add to Favorites

The ACR and the Arthritis Foundation Present New Guidelines Offering Therapeutic Approaches and Treatment Options for Juvenile Idiopathic Arthritis

Today, the American College of Rheumatology (ACR), in partnership with the Arthritis Foundation (AF), released two guidelines on juvenile idiopathic arthritis (JIA). One guideline aims to provide therapeutic approaches for non-systemic...
30-Apr-2019 3:00 PM EDT Add to Favorites

American College of Rheumatology Applauds Introduction of Bipartisan Step Therapy Legislation

The American College of Rheumatology today praised Representative Raul Ruiz, MD (D-CA) and Representative Brad Wenstrup, MD (R-OH) for introducing the “Safe Step Act” (H.R. 2279). If enacted, H.R. 2279 would place reasonable parameters around...
11-Apr-2019 1:05 PM EDT Add to Favorites

ACR Leads Group Urging CMS to Implement Patient Step Therapy Safeguards and Clarify Existing Protections

The American College of Rheumatology and 24 other patient and provider organizations are calling on CMS to immediately add step therapy safeguards to the agency's proposal allowing Medicare Advantage plans to utilize step therapy for Part B drugs.
8-Apr-2019 4:10 PM EDT Add to Favorites

American College of Rheumatology Targets Step Therapy and Drug Pricing in New Position Statements

The American College of Rheumatology (ACR) has released new drug pricing and step therapy position statements that they hope legislators will consider as they continue to explore policy and regulatory options to make drugs more affordable and...
1-Apr-2019 9:05 AM EDT Add to Favorites

COMPLIMENTARY PRESS REGISTRATION AVAILABLE FOR 2019 STATE-OF-THE-ART CLINICAL SYMPOSIUM

The American College of Rheumatology (ACR) welcomes members of the press to write about rheumatology research presented at the State-of-the-Art Clinical Symposium (SOTA) in Chicago, IL, on April 5-7.
27-Feb-2019 12:15 PM EST Add to Favorites

American College of Rheumatology Responds to CMS Medicare Part D and Medicare Advantage Proposed Rule

In comments submitted to the Centers for Medicare and Medicaid Services (CMS), the American College of Rheumatology (ACR) expressed its continuing concern with a recent CMS policy allowing Medicare Advantage (MA) plans to utilize step therapy for...
24-Jan-2019 3:05 PM EST Add to Favorites

Rheumatology Community Urges CMS to Proceed with Caution When Considering IPI Drug Pricing Model

– In comments submitted to the Centers for Medicare and Medicaid Services (CMS), the American College of Rheumatology (ACR) urged the agency to proceed with caution when considering the International Pricing Index (IPI) drug pricing model, which...
27-Dec-2018 1:05 PM EST Add to Favorites

see all news